title: Signal transduction and procoagulant state of human cord blood--progenitor-derived endothelial cells after interleukin-1alpha stimulation.
abstract: Isolation of endothelial progenitors from human umbilical cord blood generated great hope in vascular tissue engineering. However, before clinical use, progenitor derived endothelial cells (PDECs) have to be compared with mature endothelial cells (ECs). The aim of this study was to explore the behavior of PDECs exposed to a proinflammatory cytokine (interleukin-1alpha; IL-1alpha) according to the mitogen-activated protein (MAP) kinase and nuclear factor (NF)-kappaB signal transduction pathways as well as procoagulant activity (PCA). CD34(+) mononuclear cells were isolated using magnetic beads, cultured, and compared with human saphenous vein ECs (HSVECs). PDECs express endothelial markers: CD31, VE-cadherin, von Willebrand factor, KDR, and incorporate acetylated low-density lipoprotein (Dil-Ac-LDL). IL-1alpha similarly activates c-Jun N-terminal protein kinase (JNK) and p38 pathways in HSVECs and PDECs, whereas extracellular signal-related kinase (ERK)1/2 phosphorylation is lower in PDECs than in HSVECs. Low ERK1/2 phosphorylation in PDECs was specific to IL-1alpha as vascular endothelial growth factor (VEGF) similarly stimulated ERK1/2 pathway. With respect to inhibitor of NF-kappa B (Ikappa B) degradation, NF-kappa B translocation and phosphorylation, the NF-kappa B pathway is comparable in HSVECs and PDECs after stimulation. PCA and tissue factor level induced by IL-1alpha are lower in PDECs than in HSVECs. Thus, our data show that PDECs display the characteristics of functional mature ECs under IL-1alpha stimulation. However, we observed significant differences between PDECs and HSVECs related to both ERK1/2 pathway activation and tissue factor production.
authors.affiliation: INSERM, U.577, Bordeaux, France.
authors.forename: Richard
authors.initials: R
authors.lastname: Daculsi
authors.forename: Murielle
authors.initials: M
authors.lastname: Rémy-Zolghadri
authors.forename: Maritie
authors.initials: M
authors.lastname: Grellier
authors.forename: Véronique
authors.initials: V
authors.lastname: Conrad
authors.forename: Philippe
authors.initials: P
authors.lastname: Fernandez
authors.forename: Reine
authors.initials: R
authors.lastname: Bareille
authors.forename: Laurence
authors.initials: L
authors.lastname: Bordenave
mesh_terms: D000943:Antigens, Differentiation / Q000096:biosynthesis; D002478:Cells, Cultured; D042783:Endothelial Cells / Q000166:cytology / Q000378:metabolism*; D005312:Fetal Blood / Q000166:cytology / Q000378:metabolism*; D005786:Gene Expression Regulation / Q000187:drug effects / Q000502:physiology; D006801:Humans; D053582:Interleukin-1alpha / Q000494:pharmacology*; D020935:MAP Kinase Signaling System / Q000187:drug effects* / Q000502:physiology; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D013234:Stem Cells / Q000166:cytology / Q000378:metabolism*; D013925:Thromboplastin / Q000096:biosynthesis*
chemical_list: D000943:Antigens, Differentiation; D053582:Interleukin-1alpha; D013925:Thromboplastin; D011505:Protein-Tyrosine Kinases